Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 13,169 | 12,581 | 11,458 | 13,698 | 12,158 |
| Income taxes - deferred | 1,410 | -4,267 | -2,548 | -1,802 | -1,661 |
| Accounts receivable | 998 | 1,282 | -1,806 | 17,169 | 1,974 |
| Accounts payable and accrued liabilities | -8,697 | 9,377 | -590 | -6,693 | -17,024 |
| Other Working Capital | -11,932 | 15,508 | 5,290 | -7,235 | -11,143 |
| Other Operating Activity | 3,966 | -3,600 | 6,139 | 29 | 14,210 |
| Operating Cash Flow | $-1,086 | $30,881 | $17,943 | $15,166 | $-1,486 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -685 | -850 | 1,483 | -227 | -158 |
| Purchase Of Investment | -42,697 | -36,428 | -95,319 | -53,124 | -76,482 |
| Sale Of Investment | 71,870 | 22,316 | 82,353 | 81,750 | 75,483 |
| Purchase Sale Intangibles | -16,735 | -10,082 | -1,281 | -60 | 0 |
| Other Investing Activity | 0 | 678 | 10,863 | 7,417 | 5,357 |
| Investing Cash Flow | $11,753 | $-24,366 | $-1,901 | $35,756 | $4,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 747 | 545 | 0 | 2,706 | 1,443 |
| Debt Repayment | -7,912 | -2,611 | -12,094 | -3,350 | -5,884 |
| Common Stock Repurchased | -1,242 | 0 | -19,083 | -9,833 | -13,951 |
| Other Financing Activity | -2,955 | -831 | -4,521 | -762 | -3,703 |
| Financing Cash Flow | $-11,362 | $-2,897 | $-35,698 | $-11,239 | $-22,095 |
| Exchange Rate Effect | -1,333 | 456 | 999 | -109 | 1,007 |
| Beginning Cash Position | 62,835 | 58,761 | 77,418 | 37,844 | 56,218 |
| End Cash Position | 60,807 | 62,835 | 58,761 | 77,418 | 37,844 |
| Net Cash Flow | $-695 | $3,618 | $-19,656 | $39,683 | $-19,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,086 | 30,881 | 17,943 | 15,166 | -1,486 |
| Capital Expenditure | -17,423 | -10,990 | -1,722 | -287 | -158 |
| Free Cash Flow | -18,509 | 19,891 | 16,221 | 14,879 | -1,644 |